Empowering health.
Our Technology Adjuvance Technologies has developed the ability to synthesize saponin adjuvants such as QS-21, a critical component of the…
Lincoln, NE – June 11, 2021 – Adjuvance Technologies Inc. announced today that it has been selected to deliver a…
Adjuvance Technologies Presents Data at the Annual Conference on Vaccinology Research (ACVR) Pre-clinical data on influenza and COVID-19 demonstrate benefits…
Adjuvance Technologies announced today that it has been awarded supplemental contract funding from The National Institute of Allergy and Infectious…
Adjuvance Technologies 1225 L Street, Suite 600 Lincoln, NE 68508 Phone: 402-817-5050
